Misplaced Pages

Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies and the common cold. It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant.

In 2021, it was the 279th most commonly prescribed medication in the United States, with more than 800,000 prescriptions.

References

1. "Allegra-D Product information". Health Canada. 25 April 2012. Retrieved 2 June 2022.
2. ^ "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 3 December 2020. Retrieved 2 June 2022.
3. "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 30 August 2021. Retrieved 2 June 2022.
4. Mansfield LE (May 2006). "Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis". Expert Opinion on Pharmacotherapy. 7 (7): 941–51. doi:10.1517/14656566.7.7.941. PMID 16634716. S2CID 23165002.
5. "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
6. "Fexofenadine; Pseudoephedrine - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

• Medicine

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Combination drugs
• Decongestants
• Sanofi
• Pharmacology stubs